Fischer Medical Ventures Ltd Stock Price Today (NSE: FISCHER)
Fundamental Score
Fischer Medical Ventures Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Fischer Medical Ventures Ltd share price today is ₹39.13, up +0.31% on NSE/BSE as of 31 July 2026. Fischer Medical Ventures Ltd (FISCHER) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹2.52K (Cr). The 52-week high for FISCHER share price is ₹1158.00 and the 52-week low is ₹31.05. At a P/E ratio of 81.32x, FISCHER is currently trading above its industry average P/E of 36.70x. The company has a Return on Equity (ROE) of 8.59% and a debt-to-equity ratio of 0.28.
Fischer Medical Ventures Ltd Share Price Chart — NSE/BSE Historical Performance
Fischer Medical Ventures Ltd share price chart: -4.49% return over the past month. 52-week high ₹1158.00, 52-week low ₹31.05.
Fischer Medical Ventures Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹39.20 | ₹40.27 | ₹37.62 | ₹39.13 | 45.76L (Cr) | |
| ₹35.74 | ₹39.33 | ₹35.36 | ₹39.01 | 42.14L (Cr) | |
| ₹36.87 | ₹37.00 | ₹35.50 | ₹35.76 | 23.13L (Cr) | |
| ₹38.13 | ₹38.13 | ₹36.62 | ₹36.87 | 24.83L (Cr) | |
| ₹38.58 | ₹38.58 | ₹37.54 | ₹37.70 | 19.23L (Cr) | |
| ₹38.16 | ₹39.48 | ₹37.71 | ₹37.94 | 21.82L (Cr) | |
| ₹39.50 | ₹39.50 | ₹38.47 | ₹39.03 | 20.09L (Cr) | |
| ₹39.92 | ₹41.00 | ₹39.60 | ₹39.98 | 34.67L (Cr) | |
| ₹40.25 | ₹40.25 | ₹39.00 | ₹39.92 | 38.57L (Cr) | |
| ₹38.50 | ₹39.80 | ₹37.77 | ₹39.27 | 26.01L (Cr) |
Fischer Medical Ventures Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹41.90 | ₹42.37 | ₹35.36 | ₹39.13 | -6.61% | |
| ₹36.24 | ₹42.11 | ₹31.05 | ₹41.72 | +15.12% | |
| ₹37.96 | ₹39.77 | ₹33.33 | ₹38.14 | +0.47% | |
| ₹42.47 | ₹42.78 | ₹36.60 | ₹37.96 | -10.62% | |
| ₹37.06 | ₹40.69 | ₹32.01 | ₹40.50 | +9.28% | |
| ₹37.39 | ₹46.43 | ₹35.70 | ₹38.26 | +2.33% | |
| ₹42.30 | ₹43.70 | ₹33.94 | ₹38.51 | -8.96% | |
| ₹48.94 | ₹50.48 | ₹41.00 | ₹41.62 | -14.96% | |
| ₹119.29 | ₹119.40 | ₹40.79 | ₹48.08 | -59.69% | |
| ₹112.10 | ₹121.70 | ₹91.53 | ₹117.71 | +5.00% | |
| ₹1067.30 | ₹1158.00 | ₹105.20 | ₹111.00 | -89.60% | |
| ₹966.95 | ₹1085.00 | ₹944.90 | ₹1056.75 | +9.29% |
AI Research Briefing
Powered by Gemini · 2026-04-15
Overvalued micro-cap banking on a risky transformation story in a hot sector; too much hope, not enough proof.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Trading was suspended on April 1st in anticipation of FY26 results. The window will reopen 48 hours post-results declaration. Balaji Gandla was appointed Company Secretary & Compliance Officer, effective March 24, 2026.
CORE STORY (THE REAL GAME)
- Q3 FY26 results showed massive YoY growth
- ₹9.29 crore order win boosts revenue
- Expansion into Indonesian market
- Further order wins
- Successful integration of Indonesian subsidiary
- Faster-than-expected growth in the Indian medical devices market
- Micro-cap liquidity risk
- High valuation (P/E 157.52x)
- Unproven transformation story
FII holdings are slightly up (Δ 0.02%), but insignificant.
The Indian medical equipment market is projected to reach USD 65.39 Billion by 2034, growing at a CAGR of 8.30% from 2026-2034.
Time Medical International Ventures (India) secured a ₹9.29 crore order from Tamil Nadu Animal Husbandry.
No free cash flow reported.
The next 3-6 months will be crucial in determining if the company can sustain its growth momentum. Watch for further order wins and successful integration of the Indonesian subsidiary.
Primary Thesis Risk
Transformation story fails, and the company reverts to being a low-growth chemical business with a sky-high valuation.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Fischer Medical Ventures Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Fischer Medical Ventures Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of FISCHER across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Strong Revenue Growth (98.76%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Conservative Debt Levels (D/E: 0.28)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (8.99x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (62.14%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Risk Factors
4 factors identified
Below-Average Return on Equity (8.59%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 81.32x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-641.98%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Limited Institutional Interest (FII+DII: 6.35%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
Fischer Medical Ventures Ltd vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Fischer Medical Ventures Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Fischer Medical Ventures LtdFischer Medical...Selected✓ FISCHER • 524743 | 21.9/100 | ₹39.13₹39 | ₹2522.43₹2522.43 | 81.32Average 81.3 Average | 8.59%Poor 8.59% Poor | 11.43%Average 11.43% Average | 0.28Excellent 0.3 Excellent | — — | — — | 0.01% |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 55.6/100 | ₹1702.00₹1702 | ₹17395.50₹17395.50 | 53.16Average 53.2 Average | 11.15%Average 11.15% Average | 14.04%Average 14.04% Average | 0.11Excellent 0.1 Excellent | 19.35%Excellent 19.35% Excellent | 19.02%Excellent 19.02% Excellent | 0.20% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 17.1/100 | ₹314.60₹315 | ₹1588.16₹1588.16 | 105.46Average 105.5 Average | 2.38%Poor 2.38% Poor | 4.56%Poor 4.56% Poor | 0.62Good 0.6 Good | -26.20%Poor -26.20% Poor | 13.04%Good 13.04% Good | 0.00% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 69.6/100 | ₹212.69₹213 | ₹1227.22₹1227.22 | 36.70Average 36.7 Average | 14.80%Average 14.80% Average | 14.86%Average 14.86% Average | 0.05Excellent 0.1 Excellent | 103.10%Excellent 103.10% Excellent | 24.69%Excellent 24.69% Excellent | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 67.9/100 | ₹413.05₹413 | ₹782.87₹782.87 | 26.76Average 26.8 Average | 19.56%Good 19.56% Good | 24.40%Excellent 24.40% Excellent | 0.49Excellent 0.5 Excellent | 84.72%Excellent 84.72% Excellent | 38.54%Excellent 38.54% Excellent | 0.00% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 64.4/100 | ₹376.20₹376 | ₹547.99₹547.99 | 30.06Average 30.1 Average | 18.19%Good 18.19% Good | 19.64%Good 19.64% Good | 0.36Excellent 0.4 Excellent | 68.05%Excellent 68.05% Excellent | 31.02%Excellent 31.02% Excellent | 0.00% |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 61.5/100 | ₹401.65₹402 | ₹465.72₹465.72 | 21.74Average 21.7 Average | 18.51%Good 18.51% Good | 24.67%Excellent 24.67% Excellent | 0.00Excellent 0.0 Excellent | 24.33%Excellent 24.33% Excellent | 20.33%Excellent 20.33% Excellent | 0.26% |
38.2/100 | ₹147.10₹147 | ₹285.51₹285.51 | 56.65Average 56.6 Average | 7.54%Poor 7.54% Poor | 12.64%Average 12.64% Average | 0.10Excellent 0.1 Excellent | 42.43%Excellent 42.43% Excellent | 16.12%Excellent 16.12% Excellent | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 16.5/100 | ₹343.60₹344 | ₹260.07₹260.07 | 123.84Average 123.8 Average | 1.12%Poor 1.12% Poor | 3.30%Poor 3.30% Poor | 0.01Excellent 0.0 Excellent | -46.15%Poor -46.15% Poor | -7.19%Poor -7.19% Poor | 0.00% |
20.7/100 | ₹110.60₹111 | ₹216.85₹216.85 | 21.41Average 21.4 Average | 10.45%Average 10.45% Average | 13.18%Average 13.18% Average | 0.65Good 0.7 Good | — — | — — | 0.45% | |
32.1/100 | ₹193.50₹194 | ₹215.42₹215.42 | 23.96Average 24.0 Average | 11.99%Average 11.99% Average | 15.14%Good 15.14% Good | 0.03Excellent 0.0 Excellent | — — | — — | 0.00% | |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price17395.50 Cr
- Tarsons Products Ltd share price1588.16 Cr
- Laxmi Dental Ltd share price1227.22 Cr
- OSEL DEVICES LIMITED share price782.87 Cr
- HSIL Limited share price547.99 Cr
Fischer Medical Ventures Ltd PE Ratio History
Historical price-to-earnings ratio for FISCHER — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2025 | ₹0.22 | ₹41.62 | 189.2x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Fischer Medical Ventures Ltd Quarterly Performance
Latest quarterly metrics for FISCHER — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
98.76%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-641.98%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Fischer Medical Ventures Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for FISCHER — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Fischer Medical Ventures Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Fischer Medical Ventures Ltd (FISCHER) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Fischer Medical Ventures Ltd
About FISCHER (Fischer Medical Ventures Ltd)
Fischer Medical Ventures Ltd is a dynamic force in the medical equipment and supplies sector, dedicated to innovating and delivering comprehensive healthcare solutions across India... and beyond. As a multifaceted company, Fischer integrates manufacturing, distribution, leasing, and maintenance services to provide a seamless experience for its diverse clientele. Going beyond conventional offerings, Fischer is committed to addressing critical healthcare challenges through its wide-ranging portfolio encompassing advanced imaging technologies, cutting-edge screening tools, and pioneering digital health platforms. With a focus on preventative and diagnostic care, Fischer Medical Ventures strives to make a tangible impact on patient outcomes and improve access to quality healthcare. At the heart of Fischer's innovative approach lies its commitment to leveraging technology for the betterment of healthcare. Their product suite showcases a range of advanced diagnostic equipment, including sophisticated magnetic resonance imaging (MRI) and computed tomography (CT) systems. Fischer also champions proactive health management through its preventative health kiosks and e-health access points. Furthermore, their focus is evident in the range of handheld X-ray devices for cancer and TB screening, demonstrating their dedication to making healthcare solutions accessible and effective. By embracing forward-thinking solutions, Fischer Medical Ventures is driving advancements in diagnostics and preventative care for a healthier future. Fischer Medical Ventures distinguishes itself by seamlessly blending medical technology with holistic wellness solutions. This unique approach extends beyond equipment to include innovative health monitoring technologies like spincare, nutraceuticals derived from plant extracts, and mental health solutions. The company is also at the forefront of contactless screening solutions, adapting to the evolving needs of healthcare environments. This integrated approach reinforces Fischer's commitment to providing comprehensive, accessible, and technologically advanced solutions that address a wide spectrum of healthcare needs and improves the quality of life for individuals and communities.
Company Details
Key Leadership
Corporate Events
FISCHER Share Price: Frequently Asked Questions
What is the current share price of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd (FISCHER) trades at ₹39.13 on NSE and BSE. Market cap ₹2.52K (Cr). Educational data only.
What is the P/E ratio of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd has a P/E of 81.32x vs industry average 36.70x.
What is the Bull Run score for Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd has a Bull Run score of 21.9/100 based on 25+ financial parameters.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd has a dividend yield of 0.01%. Past dividends don't guarantee future payments.
What is the ROE of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd has ROE of 8.59%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Fischer Medical Ventures Ltd?
Fischer Medical Ventures Ltd has debt-to-equity of 0.28.
Is Fischer Medical Ventures Ltd a good investment?
Bull Run gives Fischer Medical Ventures Ltd a score of 21.9/100. This is not investment advice — consult a SEBI-registered advisor.